Does Early Prostate Cancer Screening Do More Harm Than Good?

David Samadi, MD, urologic oncologist, director of males’s well being, St. Francis Hospital, Roslyn, NY.

Otis W. Brawley, MD, Bloomberg distinguished professor of oncology and epidemiology, Johns Hopkins University, Baltimore.

James Eastham, MD, chief, Urology Service, Memorial Sloan Kettering Cancer Center, New York City.

Maurie Markman, MD, medical oncologist; president of medication and science, Cancer Treatment Centers of America.

National Comprehensive Cancer Network: “NCCN Guidelines.”

Rachel Darwin, spokeswoman, National Comprehensive Cancer Network.

American Urological Association: “Early Detection of Prostate Cancer.”

The New York Times: “Debating the Value of PSA Prostate Screening.”

Urology Times: “The great prostate cancer ‘hoax’: A call to arms.”

Premiere Medical Group: “Confronting A Controversy — The PSA Question.”

American Society for Clinical Oncology: “Decision Aid Tool: Prostate Cancer Screening With PSA Testing.”

Investigative and Clinical Urology: “Prostate Cancer Screening.”

Oncotypeiq.com: “About the Oncotype DX Genomic Prostate Score Assay.”

JAMA Oncology: “Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial.”

CyberKnife.com: “A precise, accurate and convenient treatment solution for prostate cancer.”

MDAnderson.org: “Proton Therapy for Prostate Cancer.”

Urology Today: “The challenges of prostate cancer management.”

American Cancer Society: “Tests to Diagnose and Stage Prostate Cancer,”  “What’s New in Prostate Cancer Research.”